UY39108A - Compuestos para su uso en el tratamiento de la infección por coronavirus - Google Patents
Compuestos para su uso en el tratamiento de la infección por coronavirusInfo
- Publication number
- UY39108A UY39108A UY0001039108A UY39108A UY39108A UY 39108 A UY39108 A UY 39108A UY 0001039108 A UY0001039108 A UY 0001039108A UY 39108 A UY39108 A UY 39108A UY 39108 A UY39108 A UY 39108A
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- treatment
- coronavirus infection
- infection
- coronavirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382152 | 2020-03-02 | ||
| EP20382192 | 2020-03-13 | ||
| EP20382266 | 2020-04-02 | ||
| EP20382339 | 2020-04-27 | ||
| EP20382815 | 2020-09-16 | ||
| EP20382816 | 2020-09-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39108A true UY39108A (es) | 2021-09-30 |
Family
ID=74797953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039108A UY39108A (es) | 2020-03-02 | 2021-03-02 | Compuestos para su uso en el tratamiento de la infección por coronavirus |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20230158102A1 (https=) |
| EP (1) | EP4114436A1 (https=) |
| JP (1) | JP2023517295A (https=) |
| KR (1) | KR20220151181A (https=) |
| CN (1) | CN115666615A (https=) |
| AU (1) | AU2021232534A1 (https=) |
| BR (1) | BR112022017008A2 (https=) |
| CA (1) | CA3169791A1 (https=) |
| CL (1) | CL2022002398A1 (https=) |
| CO (1) | CO2022014115A2 (https=) |
| IL (1) | IL296066A (https=) |
| MX (1) | MX2022010922A (https=) |
| PE (1) | PE20231069A1 (https=) |
| PY (1) | PY2117315A (https=) |
| TW (1) | TW202144380A (https=) |
| UY (1) | UY39108A (https=) |
| WO (1) | WO2021175826A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021231521A1 (en) * | 2020-03-02 | 2022-10-06 | Pharma Mar, S.A. | PLD for use in combination in the treatment of coronavirus |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8922026D0 (en) * | 1989-09-29 | 1989-11-15 | Pharma Mar Sa | Novel anti-viral and cytotoxic agent |
| GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
| CA2405779A1 (en) | 2000-04-07 | 2001-10-18 | The Trustees Of The University Of Pennsylvania | Tamandarin and didemnin analogs and methods of making and using them |
| UA76718C2 (uk) | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
| JP2006523214A (ja) | 2003-03-21 | 2006-10-12 | ジユーリー，マデレーン・エム | タマンダリン類似物およびこれらのフラグメントそして製造方法および使用方法 |
| US7605135B2 (en) * | 2003-11-10 | 2009-10-20 | The University Of Hong Kong | Baicalin as a treatment for SARS infection |
| JP2012512839A (ja) * | 2008-12-19 | 2012-06-07 | ファルマ、マール、ソシエダード、アノニマ | 抗腫瘍性化合物 |
| WO2011020913A2 (en) | 2009-08-21 | 2011-02-24 | Pharma Mar, S.A. | Cyclodepsipeptide antiviral compounds |
| CN115461067A (zh) * | 2020-03-02 | 2022-12-09 | 法马马有限公司 | 用于炎症的化合物 |
-
2021
- 2021-03-02 US US17/908,524 patent/US20230158102A1/en active Pending
- 2021-03-02 CA CA3169791A patent/CA3169791A1/en active Pending
- 2021-03-02 TW TW110107291A patent/TW202144380A/zh unknown
- 2021-03-02 CN CN202180018709.2A patent/CN115666615A/zh active Pending
- 2021-03-02 KR KR1020227034222A patent/KR20220151181A/ko active Pending
- 2021-03-02 PE PE2022001871A patent/PE20231069A1/es unknown
- 2021-03-02 JP JP2022552932A patent/JP2023517295A/ja active Pending
- 2021-03-02 BR BR112022017008A patent/BR112022017008A2/pt unknown
- 2021-03-02 AU AU2021232534A patent/AU2021232534A1/en active Pending
- 2021-03-02 WO PCT/EP2021/055137 patent/WO2021175826A1/en not_active Ceased
- 2021-03-02 UY UY0001039108A patent/UY39108A/es unknown
- 2021-03-02 PY PY202102117315A patent/PY2117315A/es unknown
- 2021-03-02 MX MX2022010922A patent/MX2022010922A/es unknown
- 2021-03-02 IL IL296066A patent/IL296066A/en unknown
- 2021-03-02 EP EP21708649.5A patent/EP4114436A1/en active Pending
-
2022
- 2022-09-02 CL CL2022002398A patent/CL2022002398A1/es unknown
- 2022-09-30 CO CONC2022/0014115A patent/CO2022014115A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220151181A (ko) | 2022-11-14 |
| JP2023517295A (ja) | 2023-04-25 |
| CN115666615A (zh) | 2023-01-31 |
| PY2117315A (es) | 2022-05-10 |
| MX2022010922A (es) | 2022-09-29 |
| PE20231069A1 (es) | 2023-07-17 |
| AU2021232534A1 (en) | 2022-10-06 |
| TW202144380A (zh) | 2021-12-01 |
| US20230158102A1 (en) | 2023-05-25 |
| BR112022017008A2 (pt) | 2022-10-11 |
| CO2022014115A2 (es) | 2022-11-18 |
| IL296066A (en) | 2022-11-01 |
| CL2022002398A1 (es) | 2023-06-30 |
| EP4114436A1 (en) | 2023-01-11 |
| CA3169791A1 (en) | 2021-09-10 |
| WO2021175826A1 (en) | 2021-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3953330T (lt) | Nitrilo turintys junginiai, naudingi kaip antivirusiniai agentai, skirti koronavirusinei infekcijai gydyti | |
| SV2007002146A (es) | Difenilimidazopirimidina e imidazol aminas como inhibidores de beta-secretasa ref. am101727 | |
| BR112021022624A2 (pt) | Compostos para o tratamento da doença de huntington | |
| MX385731B (es) | Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
| CR20240363A (es) | Compuestos y métodos para el tratamiento de infecciones virales. | |
| EA200970572A1 (ru) | Ненуклеозидные ингибиторы обратной транскриптазы | |
| CO5700767A2 (es) | Procedimiento de tratamiento de rechazo de transplantes | |
| EA200601896A1 (ru) | Производные пролина и их применение в качестве ингибиторов дипептидилпептидазы iv | |
| CO2022000481A2 (es) | Inhibidores de enzimas | |
| HRP20050516B1 (hr) | N-alkil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi | |
| MX392601B (es) | Análogos sintéticos de las ecteinascidinas y su uso como agentes antitumorales. | |
| CO2022000270A2 (es) | Inhibidores de enzimas | |
| EA200970529A1 (ru) | Антивирусная композиция и способ ее применения | |
| JOP20230157A1 (ar) | طرق مُعالجة فيروس كورونا | |
| CL2008000202A1 (es) | Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor. | |
| AR077139A1 (es) | Composiciones farmaceuticas utiles para tratar el vch | |
| MX388378B (es) | Compuestos de aza-indazol para usar en lesiones de tendones y/o ligamentos. | |
| CL2007002387A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de artritis y dolor. | |
| ECSP045397A (es) | 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS | |
| MX2025002677A (es) | Moduladores de la alfa-1 antitripsina | |
| MX2023009677A (es) | Inhibidores de enzimas. | |
| CO2022014115A2 (es) | Compuestos para su uso en el tratamiento de la infección por coronavirus | |
| EA200901236A1 (ru) | Замещённые фенокси- и фенилтиопроизводные для лечения пролиферативных нарушений | |
| ECSP066484A (es) | Compuestos y metodos para el tratamiento de dislipidemia | |
| BRPI0821114A2 (pt) | Composto, uso de um composto e método para tratar qualquer mamífero afetado por câncer |